Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA.

J Neurosci. 2005 Aug 24;25(34):7709-17.

2.

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.

Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A.

Neuroimage. 2008 Jan 15;39(2):619-33. Epub 2007 Sep 21.

PMID:
17962045
3.

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.

Brain. 2006 Nov;129(Pt 11):2856-66. Epub 2006 Jul 19.

4.
5.

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC.

Brain. 2007 Nov;130(Pt 11):2837-44. Epub 2007 Oct 10.

6.

Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease.

Kemppainen N, Laine M, Laakso MP, Kaasinen V, Någren K, Vahlberg T, Kurki T, Rinne JO.

Eur J Neurosci. 2003 Jul;18(1):149-54.

PMID:
12859348
7.

Mapping of temporal and parietal cortex in progressive nonfluent aphasia and Alzheimer's disease using chemical shift imaging, voxel-based morphometry and positron emission tomography.

Zahn R, Buechert M, Overmans J, Talazko J, Specht K, Ko CW, Thiel T, Kaufmann R, Dykierek P, Juengling F, Hüll M.

Psychiatry Res. 2005 Nov 30;140(2):115-31. Epub 2005 Oct 25.

PMID:
16253483
8.

Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.

Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM.

Neuroimage. 2009 Feb 1;44(3):724-8. doi: 10.1016/j.neuroimage.2008.10.003. Epub 2008 Nov 1.

PMID:
19013250
9.

Functional imaging of cognition in Alzheimer's disease using positron emission tomography.

Salmon E, Lekeu F, Bastin C, Garraux G, Collette F.

Neuropsychologia. 2008;46(6):1613-23. doi: 10.1016/j.neuropsychologia.2007.11.022. Epub 2007 Dec 3. Review.

PMID:
18191961
10.

Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease.

Ziolko SK, Weissfeld LA, Klunk WE, Mathis CA, Hoge JA, Lopresti BJ, DeKosky ST, Price JC.

Neuroimage. 2006 Oct 15;33(1):94-102. Epub 2006 Aug 14.

PMID:
16905334
11.

Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.

Rami L, Gómez-Ansón B, Bosch B, Sánchez-Valle R, Monte GC, Villar A, Molinuevo JL.

Dement Geriatr Cogn Disord. 2007;24(4):274-9. Epub 2007 Aug 23.

PMID:
17717413
12.

In vivo mapping of amyloid toxicity in Alzheimer disease.

Frisoni GB, Lorenzi M, Caroli A, Kemppainen N, Någren K, Rinne JO.

Neurology. 2009 Apr 28;72(17):1504-11. doi: 10.1212/WNL.0b013e3181a2e896.

PMID:
19398705
13.

Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.

Mosconi L, De Santi S, Li Y, Li J, Zhan J, Tsui WH, Boppana M, Pupi A, de Leon MJ.

Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):210-21. Epub 2005 Nov 26.

PMID:
16311757
14.

Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA.

J Neurosci. 2006 Oct 4;26(40):10222-31.

15.

Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer's disease.

He Y, Chen Z, Evans A.

J Neurosci. 2008 Apr 30;28(18):4756-66. doi: 10.1523/JNEUROSCI.0141-08.2008.

17.

Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging.

Fripp J, Bourgeat P, Acosta O, Raniga P, Modat M, Pike KE, Jones G, O'Keefe G, Masters CL, Ames D, Ellis KA, Maruff P, Currie J, Villemagne VL, Rowe CC, Salvado O, Ourselin S.

Neuroimage. 2008 Nov 15;43(3):430-9. doi: 10.1016/j.neuroimage.2008.07.053. Epub 2008 Aug 12.

PMID:
18789389
18.

Episodic memory impairment in patients with Alzheimer's disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study.

Di Paola M, Macaluso E, Carlesimo GA, Tomaiuolo F, Worsley KJ, Fadda L, Caltagirone C.

J Neurol. 2007 Jun;254(6):774-81. Epub 2007 Apr 3.

PMID:
17404777
19.

Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.

Matsumoto Y, Yanase D, Noguchi-Shinohara M, Ono K, Yoshita M, Yamada M.

Dement Geriatr Cogn Disord. 2007;23(4):241-5. Epub 2007 Feb 19.

20.

Abeta amyloid deposition in the language system and how the brain responds.

Nelissen N, Vandenbulcke M, Fannes K, Verbruggen A, Peeters R, Dupont P, Van Laere K, Bormans G, Vandenberghe R.

Brain. 2007 Aug;130(Pt 8):2055-69. Epub 2007 Jun 24.

Items per page

Supplemental Content

Write to the Help Desk